Why BGPT?
logo

Paper Review — verify claims with raw data

Extract figures, tables, methods, and underlying data to audit results.

Press Enter ↵ to review



    Explore by Goal




     Quick Explanation


    Capicua (CIC) review: RTK–MAPK-controlled transcriptional repression links development, brain/immune biology, and multiple disease phenotypes
    The review synthesizes evidence that CIC is regulated mainly by RTK–RAS–MAPK signaling (via phosphorylation-dependent cytoplasmic relocalization/degradation and 14-3-3 control) and by ATXN1/ATXN1L-mediated stabilization, with downstream emphasis on ETV/PEA3 targets (ETV1/ETV4/ETV5).
    Use the graphs below to quickly see the paper’s extracted quantitative highlights (e.g., lung perinatal lethality, abdominal wall closure penetrance, and the oligodendroglioma mutation prevalence range)."



     Long Explanation


    Paper Review (Science-focused, skeptical, evidence-structured)

    Title: Regulation and function of capicua in mammals — (2020)
    1) What the review claims (compressed, evidence-anchored)
    • CIC is evolutionarily conserved and functions as a transcription factor whose DNA-binding involves an HMG-box-containing module, with mammalian roles spanning development, brain function, and immunity.
    • RTK–RAS–MAPK signaling suppresses CIC activity by phosphorylation-driven changes such as altered DNA-binding via 14-3-3 and changes in subcellular localization and stability (including nuclear degradation mechanisms).
    • ATXN1/ATXN1L stabilize CIC and help preserve CIC function, affecting developmental and neurodegenerative phenotypes where ATXN1 polyQ expansion is central to SCA1.
    • Downstream gene regulation often emphasizes ETV/PEA3 targets (ETV1/ETV4/ETV5) as key output nodes, with diverse context-dependent phenotypes across cancer and neural/immune systems.
    • Genome fusion biology: CIC–DUX4 fusion proteins can act as oncogenic drivers by activating PEA3 family genes.
    2) Visuals: quantitative highlights explicitly present in the review text
    These plots use the quantitative values included in your provided extracted-data block (e.g., 83% perinatal lethality, 70% omphalocele incidence, and 50–70% oligodendroglioma mutation prevalence range).
    3) Mechanistic framework extracted from the review
    3.1 RTK–RAS–MAPK → CIC activity suppression
    The review emphasizes that RTK signaling can cause CIC suppression by phosphorylation-linked mechanisms, including (i) modulation of CIC DNA-binding/repressor activity through 14-3-3 binding (e.g., S173), (ii) transport-related effects impacting nuclear access, and (iii) nuclear proteasomal degradation with PRAJA1, with DNA-binding prerequisite noted by the review.
    3.2 ATXN1/ATXN1L → CIC stabilization
    CIC stabilization by ATXN1 and (more prominently) ATXN1L is treated as a major determinant of CIC stability and promoter occupancy; the review states that loss of ATXN1L causes greater CIC level decrease and instability leading to proteasomal degradation.
    3.3 DNA recognition module (C1 + HMG-box) and cancer mutation hotspots
    The review relies on mechanistic DNA-binding concepts including cooperative recognition by an HMG-box and a distant C1 domain. A key experimental basis is a mode of DNA recognition where neither HMG-box nor C1 alone suffices for binding but the HMG-box+C1 module forms a specific bipartite DNA-binding element to octameric CIC sites.
    4) Disease and tissue functions: evidence type vs confidence (skeptical weighting)
    Below, “confidence” reflects how directly the review ties phenotype to mechanism; it does not assume universal applicability across tissues/species.
    • SCA1 (ATXN1–CIC complex): the review emphasizes a high-affinity CIC–ATXN1 interaction in human cells and mouse genetic evidence where partial loss of CIC attenuates pathological/behavioral abnormalities in an ATXN1 polyQ model; these are stronger causal arguments than purely correlative claims.
    • Immune phenotypes: the review attributes autoimmune-like phenotypes and follicular helper T (Tfh) differentiation control to CIC–ETV5 derepression with functional adoptive-transfer support described in the review.
    • Cancer: the review includes both fusion-driven activation logic (CIC–DUX4 as an oncogenic chimeric activator) and multiple tumor-suppressive mechanisms via derepression of ETV targets when CIC protein decreases; however, context dependence and correlative human evidence limitations remain.
    5) Critical appraisal (what’s strong vs what remains shaky)
    Strengths
    • Mechanistic coherence: the review consistently frames CIC function through upstream kinase control (RTK–MAPK) and stabilizing partners (ATXN1/ATXN1L), then connects outputs to ETV/PEA3 transcription factors.
    • Explicit recognition of knowledge gaps: the review states unresolved issues such as which factors mediate cytoplasmic translocation upon RTK activation and how ATXN1L stabilizes CIC at the molecular level.
    Limitations / possible blind spots (skeptical)
    • Axis over-centralization risk: the review notes mammalian understanding is largely limited to processes controlled by CIC–ETV1/ETV4/ETV5, so emphasizing this axis may under-represent CIC targets in other tissues/contexts.
    • Protein-vs-mRNA disconnect: the review describes cases where CIC protein levels don’t correlate with mRNA levels, implying post-transcriptional regulation and complicating translation of transcriptomics alone into functional predictions.
    • Species-model extrapolation: many mammalian conclusions rely heavily on mouse genetics and cell/cancer models, so generality to human disease subtypes may be incomplete (the review itself is a synthesis, but it does not claim full generality).
    Important epistemic note: the network above is a structuring diagram of the review’s main axes, not a quantitative mechanistic model; the review itself states multiple unresolved details for how specific steps are executed in different contexts.
    6) Actionable “next questions” to stress-test the review’s model
    • Disambiguate “cytoplasmic translocation” vs “cytoplasmic degradation”: the review notes uncertainty about whether CIC is degraded in the cytoplasm and emphasizes unclear machinery for cytoplasmic translocation.
    • Measure target selectivity beyond the ETV axis: the review lists other target genes (e.g., SPRY4/DUSP4/DUSP6/SPRED1/CCND1/CCNE1/PER2) but emphasizes incomplete cellular/organism-level effects; challenge whether ETV-centric explanations generalize across tissues and disease stages.
    Author reviews
    Author in the provided manuscript metadata: Yoontae Lee.


    Feedback:    

    Updated: April 22, 2026

     BGPT Paper Review


    Study Novelty

    60%

    As a literature review (not a primary mechanistic study), novelty primarily comes from synthesis and framing; the paper consolidates known CIC regulatory logic (RTK–MAPK, ATXN1/ATXN1L, ETV/PEA3 axes) rather than introducing new experimental results.


    Scientific Quality

    80%

    Scientifically strong as an integrative review with clear mechanistic axes and explicit gaps, but constrained by the inherent limits of review evidence (heterogeneous study types, species/model differences, and axis emphasis).


    Study Generality

    70%

    CIC is a conserved transcription factor with broad relevance, and the review covers multiple organ systems; however, its mechanistic conclusions are most fully developed around the CIC–ETV/PEA3 axis, which limits generality across all CIC targets/tissues.


    Study Usefulness

    70%

    Useful as a structured entry point into CIC regulation and disease links, especially for researchers interested in RTK–MAPK transcriptional repression and CIC/ATXN1 interplay; less directly actionable for those seeking full targetome-level or tissue-specific mechanistic certainty.


    Study Reproducibility

    60%

    As a review, it is reproducible in the sense that its claims trace to prior papers; however, reproducibility of the review’s synthesis depends on the completeness and selection of cited studies and cannot be “rerun” computationally without a specified inclusion/exclusion protocol.


    Explanatory Depth

    80%

    High explanatory depth at the level of regulatory logic (phosphorylation-dependent activity/stability control; ATXN1/ATXN1L stabilization; DNA-binding module concept) while still acknowledging unresolved molecular details and open questions.


    🎁 Authors: Collect 225 Free Science Tokens (≈ $22.5 USD)

    Claim My Author Tokens

    Use for 56 days of free BGPT access (4 tokens = 1 day) or trade/sell (≈ $22.5 USD)

     Top Data Sources ExportMCP


     Analysis Wizard



    Parses review-extracted quantitative highlights into structured arrays, then generates labeled summary plots for CIC phenotypes (lung lethality, omphalocele incidence, oligodendroglioma mutation prevalence) for rapid comparison.



     Hypothesis Graveyard


    A null hypothesis that CIC is a generic, context-independent global repressor is less likely because the review emphasizes context-dependent disease outcomes, isoform differences, and tissue-specific target wiring (e.g., differential ETV member usage).


    A strongman hypothesis that CIC effects can be fully predicted from mRNA abundance is weakened by the review’s statement that CIC protein levels may not correlate with CIC mRNA levels in cancers, implying major post-transcriptional regulation.

     Science Art


    Paper Review: Regulation and function of capicua in mammals Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Follow the Evidence

    New scientific claims, supporting evidence, and important limitations. Every Friday. No ads.


    My BGPT






     Trending